Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IRON | US
0.63
0.91%
Healthcare
Biotechnology
30/06/2024
22/04/2026
69.71
69.49
71.29
68.32
Disc Medicine Opco Inc together with its subsidiaries operates as a clinical-stage biotechnology company engages in the discovery development and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company builds a portfolio of fundamental biological pathways of red blood cell biology primarily heme biosynthesis and iron homeostasis. It also develops bitopertin for the treatment of erythropoietic porphyrias erythropoietic protoporphyria and X-linked protoporphyria. In addition the company develops DISC-0974 for the treatment of chronic kidney disease; MWTX-003 for the treatment of polycythemia vera and other hematologic disorders; and DISC-0998 for the treatment of anemia associated with inflammatory. The company is based in Watertown Massachusetts.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Midcap (2B - 10B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
34.3%1 month
35.4%3 months
71.7%6 months
59.8%-
-
3.07
0.00
0.00
-7.56
-
-
-110.80M
2.07B
2.07B
-
-
-
-
-21.16
8.00
6.08
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
6.94
Range1M
14.26
Range3M
43.93
Rel. volume
0.97
Price X volume
24.24M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc | RARE | Biotechnology | 24.61 | 2.27B | 2.12% | n/a | 214.27% |
| Celldex Therapeutics Inc | CLDX | Biotechnology | 34.21 | 2.27B | -0.12% | n/a | 0.29% |
| Vera Therapeutics Inc. Class A Common Stock | VERA | Biotechnology | 40.27 | 2.21B | 0.52% | n/a | 16.11% |
| Spruce Biosciences Inc | SPRB | Biotechnology | 52.36 | 2.16B | 1.30% | n/a | 6.24% |
| Day One Biopharmaceuticals Inc. Common Stock | DAWN | Biotechnology | 21.53 | 2.12B | 0.19% | n/a | 0.06% |
| ELVN | ELVN | Biotechnology | 44.44 | 2.10B | -3.16% | n/a | 0.06% |
| DBV Technologies S.A | DBVT | Biotechnology | 19.64 | 2.10B | -1.65% | n/a | 16.59% |
| Adeptus Health Inc | ADPT | Biotechnology | 14.2 | 2.09B | -0.07% | n/a | 93.65% |
| Sol-Gel Technologies Ltd | SLGL | Biotechnology | 73.48 | 2.05B | -3.18% | n/a | 3.99% |
| Zymeworks Inc | ZYME | Biotechnology | 28.53 | 2.03B | 0.92% | n/a | 4.94% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| HNI Corporation | HNI | Building Products & Equipment | 37.21 | 1.75B | -0.24% | 22.12 | 76.47% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 14.59 | 1.46B | -1.29% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 40.77 | 1.28B | 1.52% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 32.59 | 943.64M | -3.09% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.48 | 796.36M | -0.54% | 11.62 | 116.21% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 17.23 | 718.20M | -2.10% | 42.05 | 64.69% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.01 | 694.62M | 1.01% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 20.33 | 528.66M | 2.73% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 25.21 | 503.97M | -3.41% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 23.16 | 384.63M | -2.32% | 34.27 | 26.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.56 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.07 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 71.69 | - | Par |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 2.07B | - | Emerging |